Cancer Network spoke with Paul B. Chapman, MD, of Memorial Sloan Kettering Cancer Center, about pursuing adjuvant immunotherapy for patients with melanoma.
Paul B. Chapman, MD
Advertisement
Articles by Paul B. Chapman, MD
Cancer Network spoke with Paul B. Chapman, MD, of Memorial Sloan-Kettering Cancer Center about strategies and research surrounding optimized targeted therapy in melanoma.
Advertisement
Latest Updated Articles
Dr. Paul B. Chapman on Optimizing Targeted Therapy in MelanomaPublished: June 13th 2019 | Updated:
Dr. Paul Chapman on the Choice to Pursue Adjuvant Immunotherapy for Melanoma PatientsPublished: June 19th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
3
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
4
FDA Grants Fast Track Designation to NG-350A For pMMR Rectal Cancer
5
